Literature DB >> 27073113

Management of differentiation syndrome in an elderly patient with acute promyelocytic leukemia who subsequently developed refractory anemia with ring sideroblasts.

Ryan A Denu1,2, Rodolfo Henrich Lobo3, Ryan J Mattison2,4.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 27073113      PMCID： PMC5588882          DOI： 10.3109/10428194.2016.1165813

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  15 in total

Review 1.  Acute promyelocytic leukemia: biology and treatment.

Authors:  P Fenaux; C Chomienne; L Degos
Journal:  Semin Oncol       Date:  1997-02       Impact factor: 4.929

2.  High body mass index is an independent predictor of differentiation syndrome in patients with acute promyelocytic leukemia.

Authors:  Ramzi Jeddi; Hèla Ghédira; Samia Mnif; Emna Gouider; Pierre Fenaux; Balkis Meddeb
Journal:  Leuk Res       Date:  2009-10-01       Impact factor: 3.156

3.  Therapy-related myeloid neoplasms in patients with acute promyelocytic leukemia treated with all-trans-retinoic Acid and anthracycline-based chemotherapy.

Authors:  Pau Montesinos; José D González; José González; Chelo Rayón; Elena de Lisa; Maria L Amigo; Gert J Ossenkoppele; María J Peñarrubia; Manuel Pérez-Encinas; Juan Bergua; Guillermo Debén; María J Sayas; Javier de la Serna; Josep M Ribera; Javier Bueno; Gustavo Milone; Concha Rivas; Salut Brunet; Bob Löwenberg; Miguel Sanz
Journal:  J Clin Oncol       Date:  2010-07-12       Impact factor: 44.544

Review 4.  The incidence of secondary leukemias.

Authors:  G Leone; L Mele; A Pulsoni; F Equitani; L Pagano
Journal:  Haematologica       Date:  1999-10       Impact factor: 9.941

5.  The "retinoic acid syndrome" in acute promyelocytic leukemia.

Authors:  S R Frankel; A Eardley; G Lauwers; M Weiss; R P Warrell
Journal:  Ann Intern Med       Date:  1992-08-15       Impact factor: 25.391

6.  Myelodysplastic syndrome after acute promyelocytic leukemia: the European APL group experience.

Authors:  I Lobe; F Rigal-Huguet; A Vekhoff; B Desablens; D Bordessoule; C Mounier; A Ferrant; M Sanz; M Fey; C Chomienne; S Chevret; L Degos; P Fenaux
Journal:  Leukemia       Date:  2003-08       Impact factor: 11.528

7.  Therapy-related myelodysplastic syndrome and acute myeloid leukemia following treatment of acute myeloid leukemia: possible role of cytarabine.

Authors:  Cecilia Arana-Yi; Annemarie W Block; Sheila N Sait; Laurie A Ford; Maurice Barcos; Maria R Baer
Journal:  Leuk Res       Date:  2008-02-21       Impact factor: 3.156

8.  Long-term outcome and prognostic factors of elderly patients with acute promyelocytic leukemia.

Authors:  Takaaki Ono; Akihiro Takeshita; Yuji Kishimoto; Hitoshi Kiyoi; Masaya Okada; Takahiro Yamauchi; Motohiro Tsuzuki; Kentaro Horikawa; Mitsuhiro Matsuda; Katsuji Shinagawa; Fumihiko Monma; Shigeki Ohtake; Chiaki Nakaseko; Masatomo Takahashi; Yukihiko Kimura; Masako Iwanaga; Norio Asou; Tomoki Naoe
Journal:  Cancer Sci       Date:  2012-09-18       Impact factor: 6.716

9.  Incidence, clinical features, and outcome of all trans-retinoic acid syndrome in 413 cases of newly diagnosed acute promyelocytic leukemia. The European APL Group.

Authors:  S De Botton; H Dombret; M Sanz; J S Miguel; D Caillot; R Zittoun; M Gardembas; A Stamatoulas; E Condé; A Guerci; C Gardin; K Geiser; D C Makhoul; O Reman; J de la Serna; F Lefrere; C Chomienne; C Chastang; L Degos; P Fenaux
Journal:  Blood       Date:  1998-10-15       Impact factor: 22.113

10.  Predictive factors for all-trans retinoic acid-related differentiation syndrome in patients with acute promyelocytic leukemia.

Authors:  Houry Leblebjian; Daniel J DeAngelo; J Andrew Skirvin; Richard M Stone; Martha Wadleigh; Lillian Werner; Donna S Neuberg; Sylvia Bartel; Anne M McDonnell
Journal:  Leuk Res       Date:  2013-05-01       Impact factor: 3.156
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.